المؤلفون: Voorham, Jaco, Corradi, Massimo, Papi, Alberto, Vogelmeier, Claus F., Singh, Dave, Fabbri, Leonardo M., Kerkhof, Marjan, Kocks, Janwillem H., Carter, Victoria, Price, David

المصدر: Voorham , J , Corradi , M , Papi , A , Vogelmeier , C F , Singh , D , Fabbri , L M , Kerkhof , M , Kocks , J H , Carter , V & Price , D 2019 , ' Comparative effectiveness of triple therapy versus dual bronchodilation in COPD ' , ERJ Open Research , vol. 5 , no. 3 . https://doi.org/10.1183/23120541.00106-2019Test

مصطلحات موضوعية: acetylcysteine, antibiotic agent, azithromycin, beta adrenergic receptor stimulating agent, carbocisteine, corticosteroid, erythromycin, long acting drug, methylxanthine, muscarinic receptor blocking agent, nedocromil, phosphodiesterase IV inhibitor, salbutamol, short acting drug, theophylline, acute respiratory tract disease, aged, article, asthma, body mass, bronchodilatation, Charlson Comorbidity Index, chronic obstructive lung disease, clinical outcome, cohort analysis, comparative study, disease exacerbation, disease severity, dyspnea, eosinophil count

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/9dafda52-bebc-4302-b5bd-983b40141178Test

الإتاحة: https://doi.org/10.1183/23120541.00106-2019Test
https://hdl.handle.net/11370/9dafda52-bebc-4302-b5bd-983b40141178Test
https://research.rug.nl/en/publications/9dafda52-bebc-4302-b5bd-983b40141178Test
https://pure.rug.nl/ws/files/121201619/Comparative_effectiveness_of_triple.pdfTest

المؤلفون: Van Der Schans, S., Goossens, L.M., Boland, M.R., Kocks, J., Postma, M.J., Van Boven, J.F., Rutten-van Mölken, M.P.

المصدر: Van Der Schans , S , Goossens , L M , Boland , M R , Kocks , J , Postma , M J , Van Boven , J F & Rutten-van Mölken , M P 2016 , ' Cost-effectiveness analyses of pharmacologic maintenance treatment for chronic obstructive pulmonary disease : A systematic review ' , Value in Health , vol. 19 , no. 7 , pp. A556 . https://doi.org/10.1016/j.jval.2016.09.1210Test

مصطلحات موضوعية: phosphodiesterase IV inhibitor, chronic obstructive lung disease, cost effectiveness analysis, disease exacerbation, driver, Embase, human, maintenance therapy, Medline, monotherapy, mortality rate, pharmacoeconomics, quality adjusted life year, quality control, systematic review

العلاقة: https://research.rug.nl/en/publications/1a6687bd-f849-4e0a-b8ce-3cfbeacd2ae3Test

الإتاحة: https://doi.org/10.1016/j.jval.2016.09.1210Test
https://hdl.handle.net/11370/1a6687bd-f849-4e0a-b8ce-3cfbeacd2ae3Test
https://research.rug.nl/en/publications/1a6687bd-f849-4e0a-b8ce-3cfbeacd2ae3Test